載入...
Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
Treatment with glucocorticoid (GC) is the preferred therapy for polymyalgia rheumatica (PMR), but some patients show poor responses to the initial GC regimen or experience flares on GC tapering. Alternative therapies for patients with GC resistance have not yet been established. To evaluate pretreat...
Na minha lista:
| 發表在: | Clin Rheumatol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer London
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844628/ https://ncbi.nlm.nih.gov/pubmed/24803231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-014-2650-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|